A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors - Lillian L. Siu; Omid Hamid; Reva Schneider; Jordi Rodon. Ahnert; Scott A. Laurie; Frank Stephen. Hodi; Dong-Wan Kim; Myung-Ju Ahn; Gary Carlson; Hussein Assi; Hamza Khan; Patrick Hanafin; et al. (Clinical Cancer Research, 2026)